Viscofan (VIS) - Total Liabilities
Based on the latest financial reports, Viscofan (VIS) has total liabilities worth €504.10 Million EUR (≈ $589.34 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Viscofan (VIS) cash flow conversion to assess how effectively this company generates cash.
Viscofan - Total Liabilities Trend (2000–2025)
This chart illustrates how Viscofan's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Viscofan to evaluate the company's liquid asset resilience ratio.
Viscofan Competitors by Total Liabilities
The table below lists competitors of Viscofan ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Chicony Electronics Co Ltd
TW:2385
|
Taiwan | NT$51.36 Billion |
|
Upstart Holdings Inc
NASDAQ:UPST
|
USA | $2.18 Billion |
|
Shanghai Yuyuan Tourist Mart Co Ltd
SHG:600655
|
China | CN¥82.56 Billion |
|
China Longyuan Power Group Corporation Limited
F:6WX
|
Germany | €180.65 Billion |
|
Electric Connector Technology Co Ltd
SHE:300679
|
China | CN¥2.75 Billion |
|
Autobio Diagnostics Co Ltd
SHG:603658
|
China | CN¥2.88 Billion |
|
TISCO Financial Group Public Company Limited
BK:TISCO
|
Thailand | ฿240.46 Billion |
|
Xometry Inc
NASDAQ:XMTR
|
USA | $425.79 Million |
Liability Composition Analysis (2000–2025)
This chart breaks down Viscofan's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see VIS market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.54 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Viscofan's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Viscofan (2000–2025)
The table below shows the annual total liabilities of Viscofan from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €504.10 Million ≈ $589.34 Million |
+8.66% |
| 2024-12-31 | €463.94 Million ≈ $542.39 Million |
+3.16% |
| 2023-12-31 | €449.74 Million ≈ $525.79 Million |
+2.09% |
| 2022-12-31 | €440.52 Million ≈ $515.02 Million |
+27.31% |
| 2021-12-31 | €346.02 Million ≈ $404.53 Million |
+13.75% |
| 2020-12-31 | €304.19 Million ≈ $355.63 Million |
+1.18% |
| 2019-12-31 | €300.64 Million ≈ $351.48 Million |
+8.88% |
| 2018-12-31 | €276.12 Million ≈ $322.81 Million |
+18.44% |
| 2017-12-31 | €233.12 Million ≈ $272.55 Million |
+4.58% |
| 2016-12-31 | €222.91 Million ≈ $260.61 Million |
+12.17% |
| 2015-12-31 | €198.72 Million ≈ $232.33 Million |
-33.99% |
| 2014-12-31 | €301.03 Million ≈ $351.94 Million |
+11.88% |
| 2013-12-31 | €269.06 Million ≈ $314.56 Million |
-3.56% |
| 2012-12-31 | €279.00 Million ≈ $326.18 Million |
+12.56% |
| 2011-12-31 | €247.86 Million ≈ $289.77 Million |
-12.36% |
| 2010-12-31 | €282.80 Million ≈ $330.63 Million |
+4.44% |
| 2009-12-31 | €270.78 Million ≈ $316.57 Million |
-7.64% |
| 2008-12-31 | €293.19 Million ≈ $342.77 Million |
+8.60% |
| 2007-12-31 | €269.97 Million ≈ $315.63 Million |
-7.22% |
| 2006-12-31 | €290.98 Million ≈ $340.18 Million |
+10.10% |
| 2005-12-31 | €264.29 Million ≈ $308.99 Million |
+29.53% |
| 2004-12-31 | €204.05 Million ≈ $238.55 Million |
+13.23% |
| 2003-12-31 | €180.21 Million ≈ $210.68 Million |
-14.33% |
| 2002-12-31 | €210.34 Million ≈ $245.91 Million |
-20.41% |
| 2001-12-31 | €264.28 Million ≈ $308.97 Million |
-99.43% |
| 2000-12-31 | €46.50 Billion ≈ $54.36 Billion |
-- |
About Viscofan
Viscofan, S.A., together with its subsidiaries, manufactures, produces, and distributes casings in Spain, Rest of Europe, Middle East, Africa, Pacific Asia, North America, South America, and internationally. The company offers cellulose, collagen, fibrous, functional solutions, plastics, viscofan veggie, efan, edileaf, nutra-pharma collinstant, nutra-pharma satiscoll, and medical. It also provide… Read more